X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (109744) 109744
Newspaper Article (24256) 24256
Newsletter (20534) 20534
Book Review (11080) 11080
Publication (9433) 9433
Magazine Article (1289) 1289
Trade Publication Article (1085) 1085
Web Resource (539) 539
Book Chapter (533) 533
Conference Proceeding (422) 422
Dissertation (280) 280
Book / eBook (61) 61
Streaming Video (34) 34
Reference (32) 32
Transcript (24) 24
Government Document (23) 23
Journal / eJournal (12) 12
Paper (9) 9
Data Set (8) 8
Report (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (79622) 79622
humans (58885) 58885
staphylococcus aureus (50552) 50552
staphylococcus infections (35371) 35371
staphylococcus aureus infections (27082) 27082
bacteria (26054) 26054
microbiology (25993) 25993
female (23244) 23244
male (21416) 21416
animals (20841) 20841
infectious diseases (20655) 20655
antibiotics (19563) 19563
research (19426) 19426
staphylococcus-aureus (17314) 17314
staphylococcal infections - microbiology (16906) 16906
staphylococcus aureus - drug effects (15831) 15831
anti-bacterial agents - pharmacology (15415) 15415
health aspects (14837) 14837
hospitals (14780) 14780
infections (14363) 14363
microbial sensitivity tests (14130) 14130
infection (14044) 14044
drug resistance in microorganisms (13178) 13178
adult (12086) 12086
middle aged (11957) 11957
nosocomial infections (11460) 11460
bacterial infections (11333) 11333
staphylococcus aureus - isolation & purification (10783) 10783
drug resistance (10724) 10724
anti-bacterial agents - therapeutic use (10232) 10232
analysis (10153) 10153
medical research (9854) 9854
aged (9736) 9736
staphylococcal infections - drug therapy (9701) 9701
pharmacology & pharmacy (9609) 9609
immunology (9132) 9132
staphylococcus (7929) 7929
methicillin resistance (7912) 7912
staphylococcal infections - epidemiology (7506) 7506
resistant staphylococcus-aureus (7407) 7407
risk factors (7310) 7310
staphylococcal infections (7252) 7252
epidemiology (7167) 7167
cross infection (7099) 7099
medicine, experimental (6728) 6728
mice (6719) 6719
antibacterial agents (6542) 6542
abridged index medicus (6518) 6518
mutation (6427) 6427
mrsa (6396) 6396
escherichia-coli (6147) 6147
methicillin-resistant staphylococcus aureus (6070) 6070
adolescent (5961) 5961
pathogens (5916) 5916
staphylococcus aureus - genetics (5854) 5854
child (5821) 5821
antimicrobial agents (5690) 5690
vancomycin (5607) 5607
surgery (5424) 5424
cloning (5347) 5347
studies (5242) 5242
skin (5239) 5239
methicillin-resistant staphylococcus aureus - isolation & purification (5220) 5220
prevalence (5193) 5193
virulence (5181) 5181
care and treatment (5096) 5096
gram-positive bacteria (5090) 5090
research & development--r&d (4972) 4972
mortality (4889) 4889
bacteremia (4841) 4841
disease transmission (4805) 4805
pneumonia (4717) 4717
staphylococcus - isolation & purification (4659) 4659
proteins (4603) 4603
biofilms (4545) 4545
methicillin-resistant staphylococcus aureus - drug effects (4529) 4529
retrospective studies (4436) 4436
biochemistry & molecular biology (4432) 4432
resistance (4420) 4420
staphylococcal infections - diagnosis (4359) 4359
cross infection - microbiology (4351) 4351
medicine (4320) 4320
strains (4298) 4298
escherichia coli (4265) 4265
aged, 80 and over (4242) 4242
research article (4170) 4170
methicillin (4134) 4134
infant (4117) 4117
child, preschool (4108) 4108
identification (4026) 4026
universities and colleges (4024) 4024
staphylococcal infections - prevention & control (4005) 4005
treatment outcome (4003) 4003
bacterial proteins - genetics (3973) 3973
in-vitro (3954) 3954
genes (3936) 3936
drug resistance, bacterial (3872) 3872
infection control (3828) 3828
biotechnology & applied microbiology (3777) 3777
staphylococcus - drug effects (3756) 3756
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (57) 57
Gerstein Science - Stacks (27) 27
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Robarts - Government Pubs (4) 4
UofT at Mississauga - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Robarts - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (148438) 148438
French (1784) 1784
German (1495) 1495
Russian (1341) 1341
Japanese (1277) 1277
Spanish (1249) 1249
Polish (439) 439
Italian (321) 321
Chinese (309) 309
Portuguese (264) 264
Korean (191) 191
Turkish (186) 186
Dutch (150) 150
Czech (114) 114
Danish (79) 79
Persian (79) 79
Romanian (68) 68
Ukrainian (66) 66
Swedish (47) 47
Norwegian (43) 43
Hungarian (42) 42
Finnish (25) 25
Serbian (25) 25
Croatian (24) 24
Hebrew (18) 18
Bulgarian (17) 17
Slovak (14) 14
Lithuanian (10) 10
Slovenian (9) 9
Indonesian (5) 5
Arabic (4) 4
Hindi (4) 4
Greek (3) 3
Icelandic (3) 3
Afrikaans (1) 1
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Objective. We compared differences in the hospital charges, length of hospital stay, and mortality between patients with healthcare- and community-associated... 
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | MORTALITY | INFECTIOUS DISEASES | ESCHERICHIA-COLI | EUROPEAN HOSPITALS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | IMMUNOLOGY | NOSOCOMIAL INFECTIONS | INTENSIVE-CARE | METHICILLIN-RESISTANCE | ENTEROCOCCUS | STAPHYLOCOCCUS-AUREUS INFECTIONS | BLOOD-STREAM INFECTIONS | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | Hospitalization | Health care expenditures | Bacterial infections | Incentives | Mortality | Index Medicus | and Commentaries
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2012, Volume 40, Issue 5, pp. 396 - 407
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in... 
Infectious Disease | Infection Control | Nosocomial infection | Ventilator-associated pneumonia | Low-income countries | Bloodstream infection | Developing countries | Central line-associated bloodstream infection | Limited-resources countries | Health care-associated infection | Urinary tract infection | Catheter-associated urinary tract infection | Network | Antibiotic resistance | Hospital infection | Device-associated infection | MORTALITY | INTENSIVE-CARE UNITS | CONTROL PROGRAM | RATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PERFORMANCE FEEDBACK | SAFETY NETWORK | INFECTIOUS DISEASES | LENGTH-OF-STAY | ARGENTINEAN HOSPITALS | BLOOD-STREAM INFECTIONS | Africa - epidemiology | Prevalence | Prospective Studies | Humans | Middle Aged | Cross Infection - mortality | Child, Preschool | Infant | Male | Young Adult | Aged, 80 and over | Bacteria - classification | Adult | Female | Child | Infant, Newborn | Cross Infection - epidemiology | Latin America - epidemiology | Intensive Care Units | Europe - epidemiology | International Cooperation | Asia - epidemiology | Bacteria - isolation & purification | Adolescent | Bacterial Infections - epidemiology | Aged | Bacterial Infections - mortality | Consortia | Medical colleges | Pneumonia | Hotels and motels | Bacterial pneumonia | Staphylococcus aureus infections | Urinary tract infections | Health aspects | Antibacterial agents | Public health | Infection control | Bacteria | Intensive care | Bacterial infections | Nosocomial infections | Mortality | Index Medicus
Journal Article
Book
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 06/2018, Volume 218, Issue 6, pp. 602.e1 - 602.e16
Chronic endometritis is a persistent inflammation of the endometrial mucosa caused by bacterial pathogens such as Enterobacteriaceae, , , , , and . Although... 
microbial culture | histology | next-generation sequencing | hysteroscopy | real-time polymerase chain reaction | endometrial microbiome | bacterial pathogens | molecular microbiology diagnosis | chronic endometritis | BACTERIA | SUCCESS | CHLAMYDIA-TRACHOMATIS | CAVITY | RELIABILITY | PREVALENCE | OBSTETRICS & GYNECOLOGY | REAL-TIME PCR | EMBRYO-TRANSFER | POLYMERASE-CHAIN-REACTION | INFECTION | Gonorrhea - pathology | Culture Techniques | Klebsiella Infections - pathology | Humans | Middle Aged | Young Adult | Asymptomatic Infections | Gardnerella vaginalis - genetics | Gram-Positive Bacterial Infections - microbiology | DNA, Bacterial - analysis | Streptococcal Infections - pathology | Neisseria gonorrhoeae - genetics | Real-Time Polymerase Chain Reaction | Bacterial Infections - microbiology | Endometritis - microbiology | Gonorrhea - microbiology | Mycoplasma Infections - pathology | Endometritis - complications | Mycoplasma Infections - microbiology | Endometrium - microbiology | Sequence Analysis, DNA | Gram-Positive Bacterial Infections - pathology | Chlamydia Infections - microbiology | Escherichia coli Infections - pathology | Bacterial Infections - pathology | Escherichia coli - genetics | Klebsiella Infections - diagnosis | Endometritis - pathology | Infertility, Female - complications | Chronic Disease | Enterococcus - genetics | Hysteroscopy | Staphylococcal Infections - pathology | Mycoplasma Infections - diagnosis | Plasma Cells - pathology | Chlamydia Infections - pathology | Sensitivity and Specificity | Klebsiella pneumoniae - genetics | Adult | Female | Gonorrhea - diagnosis | Staphylococcal Infections - microbiology | Staphylococcus - genetics | Chlamydia trachomatis - genetics | Streptococcal Infections - microbiology | Escherichia coli Infections - diagnosis | Chlamydia Infections - diagnosis | Escherichia coli Infections - microbiology | Gram-Positive Bacterial Infections - diagnosis | Klebsiella Infections - microbiology | Endometritis - diagnosis | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Streptococcus - genetics | Biopsy | High-Throughput Nucleotide Sequencing | Bacterial Infections - diagnosis | Endometrium - pathology | Mycoplasma hominis - genetics | Pathology, Molecular | Microbiology | Comparative analysis | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters) tolerant to... 
aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Aminoglycosides | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 2016, Volume 35, Issue 4, pp. 579 - 583
Abstract Objective The aim of this study was to evaluate procalcitonin (PCT) diagnostic accuracy in discriminating gram-negative (GN) from gram-positive (GP)... 
Emergency | Positive blood culture | Procalcitonin | Bacterial species | Gram-positive bacteria | Sepsis | Gram-negative bacteria | Infection sites | DIAGNOSIS | MANAGEMENT | ANTIBIOTIC USE | GUIDELINES | MARKERS | CALCITONIN | EMERGENCY MEDICINE | SEPTIC SHOCK | SERUM PROCALCITONIN | RESPIRATORY-TRACT INFECTIONS | Enterococcus faecalis | Escherichia coli | Humans | Middle Aged | Escherichia coli Infections - blood | Male | Acinetobacter Infections - blood | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Endocarditis, Bacterial - blood | Staphylococcus haemolyticus | Burkholderia cepacia | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Klebsiella Infections - blood | Burkholderia Infections - microbiology | Staphylococcal Infections - blood | Staphylococcus aureus | Acinetobacter Infections - microbiology | Pneumonia, Bacterial - blood | Calcitonin - blood | Emergency Service, Hospital | Intensive Care Units | Pneumonia, Bacterial - microbiology | Escherichia coli Infections - microbiology | Biomarkers - blood | Klebsiella Infections - microbiology | Gram-Positive Bacterial Infections - blood | Enterococcus faecium | Staphylococcus hominis | Acinetobacter baumannii | Urinary Tract Infections - blood | Staphylococcus epidermidis | Catheter-Related Infections - blood | Catheter-Related Infections - microbiology | Gram-Negative Bacterial Infections - blood | Aged | Burkholderia Infections - blood | Klebsiella pneumoniae | Bacteria | Health aspects | Medical research | Medical examination | Microbiology | Emergency medicine | Analysis | Endocarditis | Medicine, Experimental | Urinary tract infections | Blood | Klebsiella | Multiple sclerosis | Intensive care | Pneumonia | Disease | Laboratories | Lung cancer | Infections | Arthritis | Family medical history | Urinary tract | Microorganisms | Burkholderia | Lupus | Pathogens | Bacterial infections | Medical instruments | Patients | Thyroid cancer | Biomarkers | Cutoffs | Diagnostic systems | Index Medicus
Journal Article
2006, Emerging infections, ISBN 9781555813772, Volume 7., xix, 381 p. ; ill.
Book
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37281 - e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Index Medicus | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article